SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer DOI Creative Commons
Ting Gao,

Baohong Jiang,

Yu Zhou

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Апрель 19, 2024

Background The transcription factor, SOX13 is part of the SOX family. proteins are crucial in progression many cancers, and some correlate with carcinogenesis. Nonetheless, biological clinical implications human breast cancer (BC) remain rarely known. Methods We evaluated survival expression data BC patients via UNLCAL, GEPIA, TIMER, Kaplan-Meier plotter databases. Immunohistochemistry (IHC) was used to verify specimens. gene alteration rates were acquired on online web cBioportal. With aid TCGA data, association between mRNA copy number alterations (CNA) methylation determined. LinkedOmics identify genes that co-expressed regulators. Immune infiltration tumor microenvironment evaluations assessed by ImmuCellAI TIMER2.0 correlated drug resistance analysis performed using GDSC2 database. Results Higher discovered tissues comparison normal tissues. Moreover, increased mutation amplification found BC. Patients levels showed worse overall (OS). Cox independently served as a prognostic indicator for poor Further, also confirmed be diverse immune cells. In terms sensitivity analysis, we higher level predicts high IC50 value most 198 drugs which resistance. Conclusion present findings demonstrated negatively relates prognosis plays an important role immunity. Therefore, may potentially adopted biomarker predicting

Язык: Английский

Exercise-augmented THSD7B exhibited a positive prognostic implication and tumor-suppressed functionality in pan-cancer DOI Creative Commons
Zhiwen Luo, Jin-guo Zhu,

Zhengyuan Fang

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Авг. 5, 2024

Breast cancer, one of the most prevalent malignancies among women worldwide, has rising incidence rates. Physical activity, particularly exercise, emerged as a significant modifier cancer prognosis, influencing both tumor biology and patient outcomes.

Язык: Английский

Процитировано

4

Nanoconjugate Carrying pH-Responsive Transferrin Receptor-Targeted Hesperetin Triggers Triple-Negative Breast Cancer Cell Death through Oxidative Attack and Assemblage of Pro-Apoptotic Proteins DOI

Dibyendu Giri,

Surya Kanta Dey,

Sounik Manna

и другие.

ACS Applied Bio Materials, Год журнала: 2024, Номер 7(11), С. 7556 - 7573

Опубликована: Ноя. 6, 2024

Triple-negative breast cancer (TNBC) is recognized as a major aggressive subtype of due to its expeditious worsening growth, extensive metastatic capability, and recalcitrance standard current treatments. Hesperetin (HSP), natural bioflavonoid from citrus fruits, demonstrates pronounced anticancer efficacy, but hydrophobicity limits clinical development. The present study reports the fabrication biocompatible pH-responsive transferrin (TF) receptor-targeted HSP-loaded poly(lactic-co-glycolic acid) (PLGA) nanobioconjugate (PLGA-HSP-TF NPs) exploration in vitro vivo antineoplastic potential. PLGA nanoparticles (NPs), PLGA-HSP NPs, PLGA-HSP-TF NPs were synthesized characterized by DLS, FTIR, FE-SEM, 1H NMR spectroscopy. stability release profile inspected, efficacy was scrutinized terms cytotoxicity, oxidative stress apoptosis biomarkers, cell cycle arrest. In tumor regression host survival studies executed Ehrlich ascites carcinoma (EAC) cell-bearing Swiss albino mice. drug uptake highly stable accomplished effectively MDA-MB-231 cells showed pH-dependent intracellular HSP, which generated excessive reactive oxygen species (ROS) that led assault TNBC cells. This elevated ROS dropped mitochondrial membrane potential triggered apoptosis-mediated death arresting at G0/G1 phase. Furthermore, unveiled significant compared free HSP with minimum toxicity dose 20 mg/kg body weight. divulges may be an astounding nanocandidate for triple-negative therapy.

Язык: Английский

Процитировано

4

Fibroblast Growth Factor Receptor 4 Promotes Triple‐Negative Breast Cancer Progression via Regulating Fatty Acid Metabolism Through the AKT/RYR2 Signaling DOI Creative Commons

Jinhui Ye,

Song Wu,

Qiang Quan

и другие.

Cancer Medicine, Год журнала: 2024, Номер 13(23)

Опубликована: Дек. 1, 2024

Triple-negative breast cancer (TNBC) is the most aggressive subtype of cancer. Previous studies have found that fibroblast growth factor receptor 4 (FGFR4) plays a crucial role in tumor development and metastasis. However, potential underlying mechanisms FGFR4 progression TNBC remain unclear.

Язык: Английский

Процитировано

4

tRF-AspGTC promotes intracranial aneurysm formation by controlling TRIM29-mediated galectin-3 ubiquitination DOI Creative Commons
Chao Wang, Bing Yu, Han Zhou

и другие.

Research, Год журнала: 2024, Номер 8

Опубликована: Дек. 18, 2024

Transfer RNA-derived small RNAs, a recently identified class of noncoding play crucial role in regulating gene expression and are implicated cerebrovascular diseases. However, the specific biological roles mechanisms transfer RNAs intracranial aneurysms (IAs) remain unclear. In this study, we that RNA-Asp-GTC derived fragment (tRF-AspGTC) is highly expressed IA tissues both humans mice. tRF-AspGTC promotes formation by facilitating phenotypic switching vascular smooth muscle cells, increasing matrix metalloproteinase 9 expression, inducing oxidative stress inflammatory responses. Mechanistically, binds to galectin-3, inhibiting tripartite motif 29-mediated ubiquitination stabilizing galectin-3. This stabilization activates toll-like receptor 4/MyD88/nuclear factor kappa B pathway, further driving inflammation. Clinically, circulating exosomal demonstrates strong diagnostic efficacy for IAs as an independent risk occurrence. These findings highlight potential promising biomarker therapeutic target IAs.

Язык: Английский

Процитировано

4

SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer DOI Creative Commons
Ting Gao,

Baohong Jiang,

Yu Zhou

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Апрель 19, 2024

Background The transcription factor, SOX13 is part of the SOX family. proteins are crucial in progression many cancers, and some correlate with carcinogenesis. Nonetheless, biological clinical implications human breast cancer (BC) remain rarely known. Methods We evaluated survival expression data BC patients via UNLCAL, GEPIA, TIMER, Kaplan-Meier plotter databases. Immunohistochemistry (IHC) was used to verify specimens. gene alteration rates were acquired on online web cBioportal. With aid TCGA data, association between mRNA copy number alterations (CNA) methylation determined. LinkedOmics identify genes that co-expressed regulators. Immune infiltration tumor microenvironment evaluations assessed by ImmuCellAI TIMER2.0 correlated drug resistance analysis performed using GDSC2 database. Results Higher discovered tissues comparison normal tissues. Moreover, increased mutation amplification found BC. Patients levels showed worse overall (OS). Cox independently served as a prognostic indicator for poor Further, also confirmed be diverse immune cells. In terms sensitivity analysis, we higher level predicts high IC50 value most 198 drugs which resistance. Conclusion present findings demonstrated negatively relates prognosis plays an important role immunity. Therefore, may potentially adopted biomarker predicting

Язык: Английский

Процитировано

3